Article ; Online: Nogo-A inhibits vascular regeneration in ischemic retinopathy.
2018 Volume 66, Issue 10, Page(s) 2079–2093
Abstract: Nogo-A is a potent glial-derived inhibitor of axon growth in the injured CNS and acts as a negative regulator of developmental angiogenesis by inhibiting vascular endothelial cell migration. However, its function in pathological angiogenesis has never ... ...
Abstract | Nogo-A is a potent glial-derived inhibitor of axon growth in the injured CNS and acts as a negative regulator of developmental angiogenesis by inhibiting vascular endothelial cell migration. However, its function in pathological angiogenesis has never been studied after ischemic injury in the CNS. Using the mouse model of oxygen-induced retinopathy (OIR) which yields defined zones of retinal ischemia, our goal was to investigate the role of Nogo-A in vascular regeneration. We demonstrate a marked upregulation of the Nogo-A receptor sphingosine 1-phosphate receptor 2 in blood vessels following OIR, while Nogo-A is abundantly expressed in surrounding glial cells. Acute inhibition of Nogo-A with function-blocking antibody 11C7 significantly improved vascular regeneration and consequently prevented pathological pre-retinal angiogenesis. Ultimately, inhibition of Nogo-A led to restoration of retinal function as determined by electrophysiological response of retinal cells to light stimulation. Our data suggest that anti-Nogo-A antibody may protect neuronal cells from ischemic damage by accelerating blood vessel repair in the CNS. Targeting Nogo-A by immunotherapy may improve CNS perfusion after vascular injuries. |
---|---|
MeSH term(s) | Angiogenesis Inducing Agents/pharmacology ; Animals ; Disease Models, Animal ; Ischemia/drug therapy ; Ischemia/metabolism ; Ischemia/pathology ; Mice, Inbred C57BL ; Neovascularization, Physiologic/drug effects ; Neovascularization, Physiologic/physiology ; Neuroglia/drug effects ; Neuroglia/metabolism ; Neuroglia/pathology ; Nogo Proteins/antagonists & inhibitors ; Nogo Proteins/immunology ; Nogo Proteins/metabolism ; Receptors, Lysosphingolipid/metabolism ; Regeneration/drug effects ; Regeneration/physiology ; Retinal Diseases/drug therapy ; Retinal Diseases/metabolism ; Retinal Diseases/pathology ; Retinal Vessels/drug effects ; Retinal Vessels/metabolism ; Retinal Vessels/pathology ; Vision, Ocular/drug effects ; Vision, Ocular/physiology |
Chemical Substances | Angiogenesis Inducing Agents ; Nogo Proteins ; Receptors, Lysosphingolipid ; Rtn4 protein, mouse ; sphingosine-1-phosphate receptor-2, mouse |
Language | English |
Publishing date | 2018-07-27 |
Publishing country | United States |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 639414-0 |
ISSN | 1098-1136 ; 0894-1491 |
ISSN (online) | 1098-1136 |
ISSN | 0894-1491 |
DOI | 10.1002/glia.23462 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2345: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.